×
Accelerate Diagnostics EBIT 2010-2024 | AXDX
Prices
Financials
Revenue & Profit
Assets & Liabilities
Margins
Price Ratios
Other Ratios
Other Metrics
Revenue
Gross Profit
Operating Income
EBITDA
Net Income
EPS
Shares Outstanding
Accelerate Diagnostics ebit from 2010 to 2024. Ebit can be defined as earnings before interest and taxes.
Historical Chart (TTM)
Quarterly
Quarterly - YOY Change
Annual
Annual % Change
Related Stocks
Company Name
Market
Cap
Intuitive Surgical (ISRG)
$171.9B
Thermo Fisher Scientific (TMO)
$161.4B
Alcon (ALC)
$45.6B
Edwards Lifesciences (EW)
$42B
IDEXX Laboratories (IDXX)
$33.3B
DexCom (DXCM)
$26.9B
IQVIA Holdings (IQV)
$25.4B
STERIS (STE)
$21.8B
Mettler-Toledo (MTD)
$20.9B
Waters (WAT)
$19.1B
SONOVA HOLDING (SONVY)
$17.3B
Fresenius Medical Care AG KGaA (FMS)
$13.9B
Hologic (HOLX)
$12.9B
Sysmex ADR (SSMXY)
$11.8B
Penumbra (PEN)
$10.7B
Globus Medical (GMED)
$9.8B
Masimo (MASI)
$8.2B
Teleflex (TFX)
$6B
Glaukos (GKOS)
$5.2B
Integer Holdings (ITGR)
$4.1B
TransMedics (TMDX)
$3B
PROCEPT BioRobotics (PRCT)
$2.9B
Veracyte (VCYT)
$2.4B
Nihon Kohden (NHNKY)
$2.1B
LivaNova (LIVN)
$1.9B
Elekta AB (EKTAY)
$1.9B
Alphatec Holdings (ATEC)
$1.5B
Integra LifeSciences Holdings (IART)
$1.2B
Pulse Biosciences (PLSE)
$1.2B
Tandem Diabetes Care (TNDM)
$1.1B